Sigyn Therapeutics, Inc. is a development-stage company, which focuses on creating therapeutic solutions that address unmet needs in global health. Its product, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. The company was founded by James A. Joyce and Craig P. Roberts on October 29, 2019 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Sigyn Therapeutics Inc market cap is $143,055.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sigyn Therapeutics Inc 52 week high is $2.00 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sigyn Therapeutics Inc 52 week low is $0.0103 as of November 18, 2026.
Sigyn Therapeutics Inc stock price today is $0.0276.
Sigyn Therapeutics Inc stock price yesterday was $0.0269.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Sigyn Therapeutics Inc's P/E ratio is -0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Sigyn Therapeutics Inc P/B ratio is -0.006.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Sigyn Therapeutics Inc 50-day moving average is $0.0315.